By Prof. Dr. med. Robert Hierner — German double board-certified specialist in Plastic, Aesthetic & Regenerative Surgery and Hand Surgery, Dubai.
It usually starts as something small and easy to ignore: a firm little lump in the palm, often near the base of the ring or little finger. There is no real pain, so most people leave it alone. Months or even years later they notice the finger no longer lies flat — it has begun to curl gently toward the palm, and it will not straighten out again. Shaking hands, putting on a glove, reaching into a pocket, or washing the face starts to become awkward.
This slow, painless bending of a finger is the signature of Dupuytren's contracture — and it is one of the most misunderstood conditions I treat. Patients frequently assume it is arthritis, a trapped nerve, or simple age-related stiffness. It is none of those things, and importantly, it does not improve on its own. The reassuring part is that it is very treatable, and the earlier it is properly assessed, the more options you keep open.
What Dupuytren's contracture actually is
Dupuytren's disease affects a thin but tough layer of connective tissue that lies just under the skin of the palm, called the palmar fascia. In a hand with Dupuytren's, this fascia gradually thickens and shortens. It first forms small nodules — the lumps patients can feel — and over time these can extend into tight cords that run up into the fingers. As a cord contracts, it behaves like a shortened rope, slowly drawing the finger down into a bent position.
Two points surprise almost every patient. First, this is not a problem with the tendons that bend your fingers — the tendons are usually completely healthy. The restriction comes entirely from the diseased fascia sitting above them. Second, it is not arthritis, not a trapped nerve, and not the same thing as "trigger finger." Because the mechanism is so specific, the treatment is specific too — which is precisely why it belongs with a surgeon who treats the hand as a dedicated specialty, a point I have explored separately in why hand surgery is its own distinct discipline. The ring and little fingers are most commonly affected, although any finger — and occasionally the thumb — can be involved.
Why does it happen, and who is most at risk?
Dupuytren's disease is strongly genetic. It is sometimes nicknamed "Viking disease" because it is far more common in people of Northern European descent, and it frequently runs in families — many patients can point to a parent or grandparent with the same curling fingers. It is also more common in men, and the likelihood rises noticeably from around the age of fifty.
Several other factors are linked to the condition or to how severe it becomes: diabetes, which is present in a meaningful share of patients; smoking; higher alcohol intake; and a history of epilepsy. In Dubai's international community, the combination of strong hereditary backgrounds and common metabolic factors such as diabetes means the condition is far from rare here. None of this is cause for guilt — but diabetes and smoking in particular are worth knowing about, because they are associated with more aggressive disease and a higher chance of it returning after treatment.
Hand surgeons pay close attention to what we call the Dupuytren diathesis — a cluster of features that signal a more aggressive form of the disease: onset before fifty, both hands affected, a strong family history, and disease appearing at other sites such as the knuckle pads or the soles of the feet. Recognising this pattern early genuinely changes how we plan treatment.
How to tell when it is time to see a hand surgeon
The single most useful check you can do at home is the table-top test. Place your hand flat on a table, palm down, and try to lay the whole hand — fingers included — completely flat against the surface. If you can, the disease is likely still early. If a finger tents up and you cannot flatten the hand, that is a clear sign the contracture has progressed enough to warrant a specialist assessment.
As a general guide, treatment is usually considered when the large knuckle joint (the MCP joint) is bent by roughly thirty degrees or more, or when there is any meaningful bend at the middle finger joint (the PIP joint). That middle joint matters a great deal: a PIP contracture is considerably harder to correct fully, and tends to give a less complete result the longer it is left. This is the core reason I discourage indefinitely "waiting and seeing" — a painless condition can still quietly cost you the full use of your hand. A lump with no bend, by contrast, often simply needs monitoring rather than any intervention.
Treatment options — from minimally invasive to surgical
There is no single treatment that is right for everyone. The appropriate choice depends on which cords are involved, which joints are affected, how severe the contracture is, your general health, and how aggressive the disease appears. Broadly, the options sit along a spectrum from least to most invasive.
Early disease: monitoring, hand therapy and radiotherapy
When the disease is genuinely early — nodules or cords, but no significant contracture yet — the most appropriate step is often careful monitoring alongside hand therapy. In this early, actively progressing stage, low-dose radiotherapy is an option with a long track record in German and European hand centres, where it is used to try to slow or halt progression before a fixed contracture develops. Long-term studies report that a high proportion of early-stage patients remain stable or even improve, with only minor side effects. It is not a treatment for an already-bent finger, but for the right early case it can be valuable — and it reflects exactly the kind of stage-specific thinking I brought with me from the German surgical tradition.
Needle release (percutaneous needle aponeurotomy)
For suitable cords, a needle release is the least invasive intervention. Using only the tip of a fine needle passed through the skin, the surgeon divides the tight cord at several points, after which the finger can be straightened. It is typically performed under local anaesthetic in a clinic setting, with minimal downtime and a quick return to normal activities. The honest trade-off is recurrence: because the diseased tissue is divided rather than removed, the contracture is more likely to return over the following years than after surgery. For many patients — particularly older patients, or those who prioritise a fast recovery — that is an entirely reasonable trade, and the procedure can be repeated if needed.
Enzyme (collagenase) injection
A second minimally invasive option is an injectable enzyme (collagenase) that chemically weakens the cord so it can be broken and the finger straightened a day or two later. It can be effective for appropriate cords. One practical point patients should know: the European brand of this medication (Xiapex) was withdrawn from the European, Asian and Australian markets in 2020 for commercial — not safety — reasons, so its availability varies considerably by region. Whether it is a realistic option for you is something to confirm at consultation rather than to assume in advance.
Surgery: limited fasciectomy
The long-established surgical treatment is limited fasciectomy, in which the diseased cords and nodules are carefully removed through a precise incision. Because the abnormal tissue is physically taken out rather than simply divided, this approach generally provides the most complete and most durable correction, with the lowest recurrence rate among the common options. The trade-off is a longer recovery than the needle or injection routes, and the real importance of dedicated hand therapy afterwards to restore full movement. For more advanced disease, severe PIP contractures, or disease that has already returned, a more extensive procedure — sometimes removing the overlying skin and replacing it with a graft (dermofasciectomy) — may be the more reliable choice.
Recurrence: why Dupuytren's is managed, not "cured"
This deserves to be stated plainly, because it sets honest expectations. Dupuytren's reflects a genetic tendency in your own tissue, and no treatment removes that tendency — so the disease can return regardless of which option you choose. In broad terms, the minimally invasive routes (needle release in particular) carry a higher chance of the contracture returning over several years, while surgical removal tends to be the most durable. None of this means treatment "fails"; it means we select the approach that best fits your stage of life, your priorities and your anatomy, and we plan for long-term follow-up rather than promising a one-time fix. Diabetes, smoking and the aggressive-diathesis features mentioned earlier all raise the chance of recurrence — another reason they form part of the conversation from the start.
The advantage of a specialist, stage-specific approach
Dupuytren's sits at the intersection of fine anatomy and judgement. The fascia lies millimetres from the nerves and vessels that supply the finger, so precision matters — and choosing the right treatment for the stage matters just as much as performing it well. My own background is in the German surgical tradition: double board certification in Plastic, Aesthetic & Reconstructive Surgery and in Hand Surgery, more than 35 years in practice, and over 10,000 procedures. I mention it here because Dupuytren's is exactly the kind of condition where matching the technique to the individual hand — rather than offering one routine to everyone — is what makes the difference. You can read more about my background on The Professor page, or about this condition specifically on our Dupuytren's disease page.
Frequently asked questions
Is Dupuytren's contracture painful?
Usually not. The nodules can occasionally feel tender in the early stages, but the condition is typically painless. That is exactly why it is so often ignored — the real problem is loss of movement and hand function, not pain.
Will my bent finger straighten on its own?
No. Dupuytren's does not resolve without treatment, and an established contracture will not reverse by itself. It tends to progress slowly over months and years, which is why early assessment is valuable — you keep more options open.
Can it come back after treatment?
Yes, it can return after any treatment, because the underlying genetic tendency remains. Minimally invasive options have a higher recurrence rate than surgery, but they also offer faster recovery and can be repeated. The right balance is an individual decision made at consultation.
Is it the same as trigger finger or carpal tunnel syndrome?
No. Trigger finger is a tendon problem and carpal tunnel syndrome is a nerve-compression problem, whereas Dupuytren's is a disease of the fascia under the skin. They can occasionally occur in the same hand, which is one more reason a proper hand-specialist examination matters. If your main symptom is numbness or tingling rather than a fixed bend, that points more toward a nerve issue and should be assessed on that basis.
The next step
If you have noticed a lump in your palm, or a finger that is beginning to curl and will not fully straighten, the most useful thing you can do is have it assessed before the middle joints become involved. Many patients are reassured to learn their disease is early and simply needs monitoring; others are glad to discover how straightforward modern treatment can be.
If you would like a clear, unhurried assessment of your hand, you are welcome to book a consultation or reach us on WhatsApp. We will explain exactly what stage you are at and which options genuinely make sense for you — including, where appropriate, simply keeping a careful eye on it.
This article is for general educational purposes and does not constitute medical advice or a guarantee of any specific outcome. Every patient is different; suitability for any treatment can only be determined through an individual medical consultation.